{
    "data": [
        {
            "title": "V2X to report EPS of $1.22 on 2025-11-03. Past performance led to 15.22% increase in share price. Stock at $57.01, down 8.85% in 52 weeks.",
            "id": "f244f1d6-1626-49fd-b731-c76176a5d7b1",
            "description": "V2X is set to release its quarterly earnings on November 3, 2025, with analysts predicting an EPS of $1.22. Investors are eager for news of exceeding expectations and positive guidance for the next quarter. In the last earnings report, V2X outperformed EPS by $0.30, resulting in a 15.22% share price increase. Over recent quarters, V2X consistently met or exceeded EPS estimates, leading to varying price changes. Currently priced at $57.01, V2X's shares have declined by 8.85% in the past year. Market sentiment is crucial, with 4 analyst ratings on V2X helping investors gauge industry expectations.",
            "link": "https://www.markets.news/headlines/f244f1d6-1626-49fd-b731-c76176a5d7b1",
            "pub_date": "2025-11-01 03:04:50",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Transcat (TRNS) to report $0.47 EPS on 2025-11-03, hoping to surpass last quarter's $0.19 beat. Past EPS: Q1 2026 - $0.59, Q4 2025 - $0.64, Q3 2025 - $0.45, Q2 2025 - $0.52. Stock price at $73.88, down 26.1% over 52 weeks. Market awaits earnings release with varied investor sentiments.",
            "id": "d65debe4-c197-4e7d-b0a6-663471849d54",
            "description": "Transcat (NASDAQ: TRNS) is set to report its quarterly earnings on November 3, 2025. Analysts predict an earnings per share (EPS) of $0.47. Previous earnings figures show Transcat beating EPS by $0.19 in the last release, resulting in a 2.68% increase in share price. The company's past performance includes beating estimates in Q1 and Q4 of 2025, with corresponding price changes of 3.00% and 16.00% respectively, and missing in Q3 and Q2 of 2025, with price drops of 13.00% and 17.00% respectively. As of October 30, shares were priced at $73.88, down 26.1% over the past year. Market sentiment suggests long-term shareholders may be bearish leading up to the earnings release. It's important for investors to focus on the company's guidance for future growth instead of just earnings beats or misses.",
            "link": "https://www.markets.news/headlines/d65debe4-c197-4e7d-b0a6-663471849d54",
            "pub_date": "2025-11-01 03:04:54",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Innovex International (NYSE: INVX) to report quarterly earnings on 11/03/2025. Analysts expect EPS of $0.28. Investors anticipate surpassing estimates and future guidance. Check Benzinga.com for full story.",
            "id": "f72645f6-158c-411a-933a-433c172bca0b",
            "description": "Innovex International, listed on NYSE as INVX, is scheduled to release its quarterly earnings report on Monday, November 3, 2025. Analysts are predicting an earnings per share (EPS) of $0.28 for the company. Investors are eagerly awaiting this announcement, hoping for results that exceed expectations and positive guidance for the upcoming quarter. This news is particularly noteworthy for new investors interested in Innovex International. More detailed information can be found on Benzinga.com.",
            "link": "https://www.markets.news/headlines/f72645f6-158c-411a-933a-433c172bca0b",
            "pub_date": "2025-11-01 03:05:00",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Helios Technologies (HLIO) expected to report EPS of $0.65 on 2025-11-03. Past earnings show share price could rise. Stock traded at $55.72 as of Oct 30, up 12.56% in 52 weeks. Analysts view it as Outperform. Check Benzinga.com for full story.",
            "id": "f0ab3cf3-1e15-43e4-a16f-4a0c2ae650a4",
            "description": "Helios Technologies (NYSE: HLIO) is set to release its quarterly earnings report on Monday, November 3, 2025. Analysts are expecting the company to report an earnings per share (EPS) of $0.65. In the previous quarter, Helios Technologies beat EPS estimates by $0.09, resulting in a 31.08% increase in share price. The stock is currently trading at $55.72, up 12.56% over the last 52 weeks. Analysts have given the company an average rating of Outperform. Investors are eagerly awaiting the earnings announcement for any news on surpassing estimates and positive guidance. Stock prices are influenced by future projections along with past performance. Full story available on Benzinga.com.",
            "link": "https://www.markets.news/headlines/f0ab3cf3-1e15-43e4-a16f-4a0c2ae650a4",
            "pub_date": "2025-11-01 03:05:04",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Gladstone Commercial (NASDAQ: GOOD) to release quarterly earnings on 2025-11-03, expected EPS $0.18, potential growth forecast.",
            "id": "8a0c994a-3094-4619-96a5-6d211a4ca244",
            "description": "On Monday, November 3, 2025, Gladstone Commercial (NASDAQ: GOOD) is set to announce its quarterly earnings report. Analysts predict the company will report an earnings per share (EPS) of $0.18. Investors will be looking for Gladstone Commercial to exceed this estimate and potentially provide optimistic guidance for the following quarter. It is advisable for new investors to consider that earnings announcements can cause significant market fluctuations. For more details, the complete article can be found on Benzinga.com.",
            "link": "https://www.markets.news/headlines/8a0c994a-3094-4619-96a5-6d211a4ca244",
            "pub_date": "2025-11-01 03:05:10",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Atlas Energy Solutions (AESI) preparing to report earnings with estimated EPS of $-0.02 on 2025-11-03. Past performance showed varied results. Stock trading at $12.07, down 39.03% in a year. Analysts rating the company as Neutral.",
            "id": "484fec2b-54b4-4f1f-ba5a-6ec299dc9964",
            "description": "Atlas Energy Solutions is set to release its quarterly earnings on November 3, 2025. Analysts project an EPS of $-0.02 for the company, which missed expectations by $0.16 in the previous quarter. Despite the miss, the share price increased by 1.37%. Over the past four quarters, EPS estimates have fluctuated, influencing price changes, with the current share price at $12.07, down 39.03% over 52 weeks. Analysts have given a neutral consensus rating based on 6 ratings. Investors should focus on the earnings report, guidance, and industry sentiments. Monitoring these factors will be crucial for investors navigating the upcoming earnings release.",
            "link": "https://www.markets.news/headlines/484fec2b-54b4-4f1f-ba5a-6ec299dc9964",
            "pub_date": "2025-11-01 03:05:12",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "EverQuote set to announce Q3 earnings on 2025-11-03 with estimated EPS of $0.48. Past misses led to share price drops. Stock trading at $20.65, up 23.63% in 52 weeks. Analysts rate EverQuote as Buy.",
            "id": "8b092f1f-e37b-43fd-98e5-97cd2ae3a6af",
            "description": "EverQuote (NASDAQ: EVER) is set to report its quarterly earnings on November 3, 2025. Analysts predict an earnings per share (EPS) of $0.48. In the previous quarter, the company missed EPS by $0.06, causing a 7.76% drop in share price. EverQuote's stock was trading at $20.65 as of October 30, up 23.63% over the last year. With a Buy consensus rating from 2 analysts, investors are eager for positive guidance for the next quarter. It's noted that stock prices can be heavily influenced by future projections rather than just past performance.",
            "link": "https://www.markets.news/headlines/8b092f1f-e37b-43fd-98e5-97cd2ae3a6af",
            "pub_date": "2025-11-01 03:05:16",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Alexander's (NYSE: ALX) set to disclose Q4 earnings on 2025-11-03, with analysts forecasting EPS of $2.50. Market optimistic for exceedance and positive guidance.",
            "id": "1a90093d-8ff9-41fe-8d95-66395501dcab",
            "description": "Alexander's (NYSE: ALX) is set to reveal its quarterly earnings on Monday, November 3, 2025. Analysts predict the company will announce an earnings per share (EPS) of $2.50. The market eagerly anticipates the update, with expectations of exceeding projections and offering positive guidance for the upcoming quarter. This information is crucial for prospective investors to consider. Check out further details on Benzinga.com.",
            "link": "https://www.markets.news/headlines/1a90093d-8ff9-41fe-8d95-66395501dcab",
            "pub_date": "2025-11-01 03:05:21",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "TG Therapeutics (NASDAQ: TGTX) to report EPS of $0.22; Shares trading at $34.02, up 44.95% in 52 weeks. Analysts expect positive guidance impact on stock price movement. Check Benzinga.com for full details.",
            "id": "32936c6b-cf48-412d-b984-52512400cf66",
            "description": "TG Therapeutics (NASDAQ: TGTX) will release its quarterly earnings report on Monday, November 3, 2025. Analysts expect the company to report an earnings per share (EPS) of $0.22. Investors are eagerly awaiting the announcement, hoping for positive news that surpasses estimates and provides favorable guidance for the next quarter. Guidance is crucial for stock price movements. In the last quarter, TG Therapeutics missed EPS by $0.13, leading to a 1.11% share price drop the following day. Past performance includes missing estimates in previous quarters. The stock was trading at $34.02 as of October 30, up 44.95% over the last 52 weeks. Analysts have given TG Therapeutics 2 ratings. More information is available on Benzinga.com.",
            "link": "https://www.markets.news/headlines/32936c6b-cf48-412d-b984-52512400cf66",
            "pub_date": "2025-11-01 03:05:23",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "",
            "id": "b453b13e-e62c-4cde-919a-aafe845ae610",
            "description": "UNSC votes to adopt draft resolution extending the mandate of the UN Support Mission in Libya (@UNSMILibya) for another year, until 31 October 2026.",
            "link": "https://www.markets.news/headlines/b453b13e-e62c-4cde-919a-aafe845ae610",
            "pub_date": "2025-11-01 03:05:37",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "China's DNA sequencing market set to reach $3.1 billion by 2030 with a 21.5% CAGR growth; driven by government support and innovation.",
            "id": "a51c3061-e423-4fee-88b2-b3d0e5c863eb",
            "description": "A recent study by BCC Research predicts that the Chinese Market for DNA Sequencing will increase from $1.2 billion in 2025 to $3.1 billion by 2030, growing at a Compound Annual Growth Rate (CAGR) of 21.5%. The report analyzes various aspects of the market in China, including products, technologies, applications, end-users, and key provinces. Factors driving this growth include government investments and strategic initiatives like the Precision Medicine Plan, making DNA sequencing more affordable and accessible. The demand for precision medicine and oncology genomics is also on the rise, leading to increased adoption of sequencing technologies. Domestic firms like BGI Genomics and Novogene are experiencing rapid growth, and advancements in AI-powered sequencing are reshaping the competitive landscape. This report provides valuable insights for stakeholders looking to capitalize on China's expanding DNA sequencing sector, driven by national healthcare ambitions and technological advancements.",
            "link": "https://www.markets.news/headlines/a51c3061-e423-4fee-88b2-b3d0e5c863eb",
            "pub_date": "2025-11-01 02:56:09",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Apple breaks records in Q4 beating analyst estimates with new all-time stock highs. CEO Tim Cook anticipates even better Q1. Strong iPhone 17 sales.",
            "id": "a974e804-34dd-4de2-9577-ebe982038dcc",
            "description": "Apple Inc's stock (NASDAQ: AAPL) surged to new all-time highs following its impressive fourth-quarter results, surpassing analyst expectations for both revenue and earnings per share. CEO Tim Cook announced that the company set multiple records in the quarter and is forecasted to break more records in the upcoming fiscal quarter. Despite a slow start in demand for the new iPhone 17, released on Sept. 19, strong sales contributed to Apple's success. Cook expressed optimism during the conference call, anticipating that the first quarter will establish additional company records. Apple's performance is outperforming its industry counterparts, with an optimistic outlook for the future. For further details, please refer to the full story on Benzinga.com.",
            "link": "https://www.markets.news/headlines/a974e804-34dd-4de2-9577-ebe982038dcc",
            "pub_date": "2025-11-01 02:59:36",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "",
            "id": "f6ce695e-66a0-4993-8c07-509dfea5b253",
            "description": "COINBASE TARGETS $2 BILLION BVNK DEAL FOR FRESH STABLECOIN PUSH",
            "link": "https://www.markets.news/headlines/f6ce695e-66a0-4993-8c07-509dfea5b253",
            "pub_date": "2025-11-01 02:52:09",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Big tech giants like Microsoft, Google, Amazon, Meta, and Apple are set to intensify AI spending boom, as portrayed in their latest earnings reports.",
            "id": "0abaf7ce-9a37-4b44-83fc-3cf8df55bfec",
            "description": "Tech giants Microsoft, Google, Amazon, Meta (formerly Facebook), and Apple are poised to lead and shape the AI trend, with recent earnings reports painting a promising picture. Analysts anticipate a surge in AI spending as these companies innovate and invest in advanced technologies. The potential for growth within the AI sector is significant, with these industry leaders expected to further capitalize on this trend.",
            "link": "https://www.markets.news/headlines/0abaf7ce-9a37-4b44-83fc-3cf8df55bfec",
            "pub_date": "2025-11-01 02:52:48",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "DOGE rebounds by 3.4% to $0.19 post mid-week selloff, testing resistance amid crypto volatility.",
            "id": "9f1a510f-895d-4822-b9c4-690ea982be7b",
            "description": "After experiencing a 3% decline on Tuesday, Dogecoin has made a recovery, showing modest gains and reaching $0.19. This increase is significant as it tests a key technical resistance level. Traders are currently analyzing the market to determine the next directional move, especially in light of the broader crypto market's volatility.",
            "link": "https://www.markets.news/headlines/9f1a510f-895d-4822-b9c4-690ea982be7b",
            "pub_date": "2025-11-01 02:55:41",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Eli Lilly beats earnings with $17.60B in Q3 revenue, EPS of $7.02. Analysts bullish on company's growth prospects.",
            "id": "df05708d-6753-47bd-bca0-1360218dc46b",
            "description": "Eli Lilly and Co. (NYSE: LLY) posted strong third-quarter results, surpassing expectations and raising its annual forecast. The company reported quarterly revenue of $17.60 billion, up 54% compared to the previous year, exceeding the expected $16.02 billion. This growth was fueled by a 62% increase in volume, partially offset by a 10% decline in realized prices. Adjusted earnings per share were reported at $7.02, a significant rise from $1.18 last year, beating the expected $5.70. Analysts at Goldman Sachs are optimistic about Eli Lilly's potential, especially with the upcoming launch of orforglipron in 2026, labeling it as a significant new product cycle in the biopharma sector. Asad Haider maintains a Buy rating and has increased the price target from $879.",
            "link": "https://www.markets.news/headlines/df05708d-6753-47bd-bca0-1360218dc46b",
            "pub_date": "2025-11-01 02:48:25",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "",
            "id": "da9f83ad-4762-44c9-b62d-793683a32bf7",
            "description": "FOREIGN MINISTERS OF CANADA, NORWAY, UK: CONCERNED BY SITUATION IN TANZANIA FOLLOWING RECENT NATIONAL ELECTIONS - JOINT STATEMENT",
            "link": "https://www.markets.news/headlines/da9f83ad-4762-44c9-b62d-793683a32bf7",
            "pub_date": "2025-11-01 02:49:26",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "",
            "id": "a82e8475-9cdb-424a-bcc4-b2c639daeda6",
            "description": "FOREIGN MINISTERS OF CANADA, NORWAY, UK: URGE TANZANIAN AUTHORITIES TO ACT WITH MAXIMUM RESTRAINT AND RESPECT THE RIGHT OF ASSEMBLY AND FREEDOM OF EXPRESSION",
            "link": "https://www.markets.news/headlines/a82e8475-9cdb-424a-bcc4-b2c639daeda6",
            "pub_date": "2025-11-01 02:50:31",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "",
            "id": "fd42bd1f-0223-4dc4-8b25-a3dffa83ecb6",
            "description": "BRAZIL FINANCE MINISTER HADDAD: GOVERNMENT HAS ESTABLISHED A RULE REQUIRING ALL INVESTMENT FUNDS TO DISCLOSE THE INDIVIDUAL TAXPAYER IDENTIFICATION OF THEIR BENEFICIARIES",
            "link": "https://www.markets.news/headlines/fd42bd1f-0223-4dc4-8b25-a3dffa83ecb6",
            "pub_date": "2025-11-01 02:50:32",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "",
            "id": "79548d49-4885-4cf2-836c-ad87a4a33eb0",
            "description": "TRUMP ADMINISTRATION BACKS REPEAL OF CAESAR ACT SANCTIONS ON SYRIA -STATE DEPARTMENT SPOKESPERSON.",
            "link": "https://www.markets.news/headlines/79548d49-4885-4cf2-836c-ad87a4a33eb0",
            "pub_date": "2025-11-01 02:40:55",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        }
    ]
}